Celularity Inc [CELU] stock is trading at $2.27, up 11.27%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CELU shares have gain 11.27% over the last week, with a monthly amount glided 3.65%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Celularity Inc [NASDAQ: CELU] stock has seen the most recent analyst activity on January 30, 2023, when Morgan Stanley downgraded its rating to a Underweight and also revised its price target to $1 from $5. Previously, Oppenheimer downgraded its rating to Perform on December 22, 2022. On June 22, 2022, H.C. Wainwright initiated with a Buy rating and assigned a price target of $15 on the stock. Truist downgraded its rating to a Hold but stick to its price target of $10 on April 06, 2022. Oppenheimer initiated its recommendation with a Outperform and recommended $9 as its price target on January 28, 2022. Morgan Stanley started tracking with a Equal-Weight rating for this stock on November 24, 2021, and assigned it a price target of $9.
Celularity Inc [CELU] stock has fluctuated between $1.00 and $5.22 over the past year. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Celularity Inc [NASDAQ: CELU] shares were valued at $2.27 at the most recent close of the market. An investor can expect a potential return of 32.16% based on the average CELU price forecast.
Analyzing the CELU fundamentals
Celularity Inc [NASDAQ:CELU] reported sales of 44.59M for the trailing twelve months, which represents a drop of -52.64%. Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at -1.06%, Pretax Profit Margin comes in at -1.65%, and Net Profit Margin reading is -1.65%. To continue investigating profitability, this company’s Return on Assets is posted at -0.61, Equity is 60.31 and Total Capital is -0.92. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -2.75.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Celularity Inc’s Current Ratio is 0.25. Further, the Quick Ratio stands at 0.19, while the Cash Ratio is 0.01. Considering the valuation of this stock, the price to sales ratio is 1.36.
